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Background: Exercise generally improves quality of life (QoL) and psychosocial functioning in 
adult populations but few randomized trials have examined dose-response effects. Purpose: The 
purpose of the present study was to report the QoL and psychosocial outcomes from the Breast 
Cancer and Exercise Trial in Alberta (BETA). Methods: Healthy but inactive postmenopausal 
women at risk for breast cancer were randomized to a year-long aerobic exercise intervention 
consisting of either 150 min/week (moderate volume group, n = 200) or 300 min/week (high 
volume group, n = 200). QoL was assessed at baseline and 1 year using the short form-36 health 
survey. Sleep quality, depression, anxiety, stress, self-esteem, and happiness were also assessed. 
Participant preference for group assignment (i.e., exercise volume) was assessed at baseline and 
tested as a moderator. Results: There were no statistically significant dose-response effects of 
aerobic exercise on any QoL, sleep quality, or psychosocial outcome. Participant preference for 
group assignment did not moderate any QoL, sleep quality, or psychosocial responses. Marital 
status was a significant moderator (p for interaction = 0.01) and obesity showed a trend towards 
being a moderator (p for interaction = 0.08) of the dose-response effects of aerobic exercise on 
global sleep quality such that unmarried and obese women improved sleep quality with the 
higher volume of aerobic exercise. Conclusions: A higher volume of aerobic exercise, 
approximately double the minimum public health guideline, did not provide additional QoL or 
psychosocial benefits compared to the minimum public health guideline in inactive 
postmenopausal women, even for women who preferred the higher volume of exercise at 
baseline. Trial Registration: Trial Registration clinicaltrials.gov identifier: NCT1435005. 
 




Exercise generally improves quality of life (QoL) and psychosocial outcomes in adult 
populations including postmenopausal women. Specifically, systematic reviews with meta-
analyses have concluded that exercise has small-to-moderate positive effects on QoL [1, 2], sleep 
quality [3], depression [2, 4], anxiety [4–6], and self-esteem [2]. In the Alberta Physical Activity 
and Breast Cancer Prevention (ALPHA) Trial, we reported that a year-long exercise intervention 
comparing 225 min/week of moderate-to-vigorous intensity aerobic exercise to no exercise 
improved several components of QoL in 320 postmenopausal women [7]. In an exploratory 
analysis, we also found that higher exercise adherence was associated with larger QoL 
improvements including some additional gains from exercising >225 min/week compared to 
150–225 min/week. In the ALPHA Trial, however, the dose-response analysis was a non-
randomized comparison that did not address the causal dose-response effects of aerobic exercise 
on QoL. Although numerous dose-response exercise trials have been conducted in adult 
populations, few have reported QoL or psychosocial outcomes [8–11]. 
 
One notable exception is the Dose-Response to Exercise in postmenopausal Women (DREW) 
Trial [8, 9]. The DREW Trial randomized over 400 sedentary overweight postmenopausal 
women to either a no exercise control group or three levels of the public health aerobic exercise 
guidelines consisting of 75 min/week (50%), 150 min/week (100%), or 225 min/week (150%). 
The DREW trial demonstrated a dose-response effect of aerobic exercise on QoL [8] and sleep 
quality [9] with the 225 min/week group having the largest and broadest effects on QoL 
components [8] and sleep quality indicators [9]. The purpose of the present study was to extend 
the results of the DREW Trial by reporting the secondary QoL and psychosocial outcomes from 
the Breast Cancer and Exercise Trial in Alberta (BETA) [12]. 
 
The BETA Trial was a primary prevention trial focused on adiposity and biomarkers related to 
breast cancer risk. In comparison to the DREW Trial, the BETA Trial compared the effects of 
300 min/week (200%) versus 150 min/week (100%) of aerobic exercise over a 1-year period in 
400 postmenopausal women [12]. We also collected a more comprehensive battery of patient-
reported outcomes including QoL, sleep quality, depression, anxiety, stress, self-esteem, and 
happiness. Finally, we incorporated a measure of participant preference for group assignment 
(i.e., exercise volume) which may be an important determinant of QoL and psychosocial 
responses when comparing more than one exercise intervention [13]. 
 
The primary outcome of the BETA Trial was adiposity [12] for which we observed that 
300 min/week of exercise was more effective in reducing total fat and other adiposity measures 
compared to 150 min/week. Based on the DREW Trial [8, 9], we hypothesized that 1 year of 
300 min/week of aerobic exercise would be superior to 150 min/week of aerobic exercise for all 
QoL, sleep quality, and psychosocial outcomes [15]. Moreover, we hypothesized that 
participants randomized to their preferred exercise volume would report more positive QoL and 
psychosocial responses compared to participants randomized to their non-preferred exercise 
volume. Finally, we explored other potential moderators of the dose-response effects of aerobic 
exercise based on plausible demographic and health factors including age, marital status, 





Setting and Participants 
 
The BETA Trial methods have been reported elsewhere [14]. Briefly, the trial was a two-center, 
two-armed, year-long randomized controlled exercise intervention trial in healthy, 
postmenopausal women. The study protocol was approved by the Alberta Cancer Research 
Ethics Committee, the Conjoint Health Research Ethics Board of the University of Calgary and 
the Health Research Ethics Board of the University of Alberta and all participants provided 
written informed consent. The trial was conducted between June 2010 and June 2014. Eligibility 
criteria included being a resident of Calgary or Edmonton, between the ages of 50 and 74 years, 
a body mass index (BMI) between 22 and 40 kg/m2, a non-smoker, able to do unrestricted 
physical activity as assessed by physician screening, and inactive (defined as <90 min/week of 
exercise or if between 90 and 120 min/week, having a VO2max <34 ml/kg/min as assessed by a 




Participants were stratified by center (Calgary, Edmonton) and BMI (<27.5, ≥27.5 m/kg2) before 
being randomized in a 1:1 ratio to the two intervention groups. The randomization sequence was 
created by the study biostatistician using a random number program with blocks randomly sized 
between four and six within strata. The study coordinator in Calgary, who was blinded to the 
randomization sequence, revealed the randomization from sealed opaque envelopes after all 




Participants were randomized to either a moderate volume of aerobic exercise based on 100% of 
the minimum public health guideline of 150 min/week (n = 200) or a high volume of aerobic 
exercise based on double (200%) the minimum public health guideline of 300 min/week 
(n = 200) [15]. Participants were asked to exercise 5 days per week at 65–75% of their heart rate 
reserve for either 30 min each day (moderate volume group) or 60 min each day (high volume 
group) and could choose any aerobic activity to perform. The exercise intervention was 
supervised 3 days/week by certified exercise trainers at fitness facilities in Calgary and 
Edmonton; the two additional days/week of exercise were unsupervised at a location determined 
by the participant. There were very few group exercise sessions although participants typically 
exercised when other trial participants were present and informal interaction did occur. Exercise 
adherence was monitored using weekly exercise logs. Heart rate monitors were worn to ensure 




Patient-reported outcomes were assessed at baseline (pre-intervention) and postintervention 
(1 year). The primary outcome of interest in the present paper was QoL assessed by the Medical 
Outcomes Study Short Form-36 Survey (SF-36) [16]. The SF-36 covers eight health domains 
including general health, physical functioning, role-physical limitations, bodily pain, vitality, 
social functioning, role-emotional limitations, and mental health. The standardized, norm-based 
domain scores were then used to create a physical component and mental component score 
(summary scales). Scores for each health domain ranged from 0 to 100 with higher scores 
indicating higher function or well-being. A single item assessed the perceived change in health 
(how much better or worse your health is now compared to 1 year ago). The SF-36 has 
demonstrated validity and reliability in clinical and nonclinical populations [16]. Secondary 
outcomes of interest included global sleep quality assessed by the Pittsburgh Sleep Quality Index 
(PSQI) [17] and various psychosocial outcomes assessed by the Center for Epidemiological 
Studies Depression Scale (CES-D) [18], the Spielberger State Anxiety Inventory [19], the 





We explored seven common moderators based on their scientific plausibility, clinical utility, 
distribution in our data set, and support in previous research [13, 23–25]. The primary moderator 
of interest was participant preference for group assignment (moderate versus high versus no 
preference). Participant preference was assessed prior to randomization by asking participants 
“Which exercise program would you prefer if you had the choice?” The three options were: (a) 
the moderate amount of aerobic exercise, (b) the higher amount of aerobic exercise, and (c) no 
preference. Secondary moderators of interest were age (<60 years versus ≥60 years), marital 
status (married or common law versus unmarried), baseline recreational physical activity 
(equivalent of <10 versus ≥10 metabolic equivalent task hours/week), baseline aerobic fitness 
(<25 versus ≥25 ml/kg/min), body mass index (<30.0 versus ≥30 kg/m2), and number of 
comorbidities (none versus ≥1). Physical activity was assessed using the validated Past Year 
Total Physical Activity Questionnaire (PYTPAQ) [26]. VO2max was estimated using a sub-
maximal, multistage, modified Balke treadmill protocol [27] and validated prediction formula 
[28]. BMI was assessed from measured standing height and weight by research staff using a 




Sample size for the trial was based on the primary endpoint of adiposity. For the present 
analyses, we estimate that our planned sample size of 400 (200 per group) would allow us to 
detect between group differences on the patient-reported outcomes of about 0.25 standard 
deviations with a power of 0.80 and two-tailed alpha of 0.05. We used intention-to-treat analyses 
that included all participants with 12-month follow-up data (complete case analysis) regardless 
of their protocol adherence. The main effect of the intervention group was assessed using linear 
models, where change in the outcome was predicted, adjusted for baseline value of outcome, and 
study site (Calgary, Edmonton). Least squares mean difference between intervention groups was 
estimated as well as least squares mean change from baseline to end of study. An exploratory 
analysis was undertaken to assess changes from baseline to end of study, combining 
randomization groups, assessing the null hypothesis of no change in outcome. Effect 
modification was assessed by linear models predicting change in outcome, adjusted for baseline 
outcome and study site, and p values for interaction between potential effect modifier and 
intervention group were estimated. To understand possible subgroup variations, the same models 
were run within each subgroup of potential effect modifier. Interaction effects were tested only 
for the SF-36 physical and mental component scores, global sleep quality, and the five 
psychosocial outcomes (anxiety, depression, stress, self-esteem, and happiness). All analyses 




A flow chart for the BETA Trial has been reported elsewhere [12]. In brief, there were 863 
women who met the inclusion criteria and 400 of these women (46%) were randomized to either 
the high (n = 200) or the moderate (n = 200) volume exercise groups. QoL data were obtained at 
postintervention (1 year) from 185 participants (93%) in the moderate volume group and 188 
participants (94%) in the high volume group. Baseline characteristics of the two groups were 
similar [12] including for the proposed moderators in the present report (Table 1). Overall, 88 
(22%) participants preferred the moderate volume intervention, 147 (37%) preferred the high 
volume intervention, and 163 (41%) had no preference. 
 
Table 1. Baseline proposed moderators overall and by group assignment in the BETA Trial 
Baseline characteristics Overall Moderate group High group 
 (n = 400) (n = 200) (n = 200) 
Participant preference, n (%)  
 Moderate volume  88 (22)  39 (20)  49 (25)  
 High volume  147 (37)  67 (34)  80 (40)  
 No preference  163 (41)  94 (47)  69 (35)  
Age (years), n (%)  
 ≥60  160 (40)  84 (42)  76 (38)  
 <60  240 (60)  116 (58)  124 (62)  
Marital status, n (%)  
 Married/common law  275 (69)  139 (70)  136 (68)  
 Unmarried  125 (31)  61 (31)  64 (32)  
Body mass index (kg/m2), n (%)  
 ≥30  155 (39)  78 (39)  77 (39)  
 <30  245 (61)  122 (61)  123 (62)  
Estimated VO2 max (ml/kg/min), n (%)  
 ≥25  270 (68)  135 (68)  135 (68)  
 <25  130 (33)  65 (33)  65 (33)  
Baseline recreational physical activity (MET hours/week), n (%)  
 ≥10  134 (34)  71 (36)  63 (32)  
 <10  266 (67)  129 (65)  137 (69)  
Presence of comorbiditiesa, n (%)  
 Yes  271 (68)  138 (69)  133 (67)  
 No  129 (32)  62 (31)  67 (34)  
a Medical conditions as reported by participants, including heart attack, angina, stroke, arthritis, osteoporosis, blood 
clots, thyroid problems, high cholesterol, and other 
MET metabolic equivalent of task 
 
Adherence to the intervention has been reported elsewhere [12]. Briefly, excluding the 3-month 
ramp-up period, the median (interquartile range) exercise level for the moderate volume group 
was 137 (111–150) min/week (91% adherence) and for the high volume group was 254 (166–
290) min/week (85% adherence). In terms of the time in the target heart rate zone based on heart 
rate monitors (excluding the ramp-up period), the median (interquartile range) was 88 (53–115) 
and 128 (66–185) min/week for the moderate and high volume groups, respectively, representing 
64 and 50% of exercise time in the targeted heart rate zones. During the 12-month period, total 
recreational physical activity increased more in the high volume group than in the moderate 
volume group (26.5 vs. 14.2 MET-h/week). VO2max increased significantly in both groups with a 
significantly larger increase in the high volume group (5.1 ml/kg/min) compared to the moderate 
volume group (4.0 ml/kg/min). 
 
Dose-Response Effects on Quality of Life and Psychosocial Outcomes 
 
There were no statistically significant dose-response effects of aerobic exercise on any QoL 
(Table 2), sleep quality (Table 3), or psychosocial outcomes (Table 4). Combining intervention 
groups, there were statistically significant main effects for time showing an overall improvement 
from baseline to 1 year in physical functioning (0.9; 95% CI 0.3 to 1.6; p<0.01), vitality (1.6; 
95% CI 0.7 to 2.5; p<0.01), general health (0.9; 95% CI 0.2 to 1.6; p<0.05), subjective sleep 
quality (−0.1; 95% CI 0.0 to −0.1; p<0.05), and self-esteem (0.6; 95% CI 0.2 to 1.0; p<0.01). 
There was also a main effect for time (p<0.01) showing a more positive health transition at 
postintervention compared to baseline (Fig. 1). Specifically, 14.4% of participants reported better 
general health at baseline compared to 1 year ago (i.e., before the intervention) whereas 74.3% 
reported better general health at 1 year compared to 1 year ago (i.e., after the intervention). 
Conversely, there were statistically significant main effects for time showing an overall decline 
in role-physical (−3.3; 95% CI −1.8 to −4.7; p<0.01), bodily pain (−3.0; 95% CI −2.1 to 
−3.9; p<0.01), social functioning (−1.4; 95% CI −0.5 to −2.3; p<0.01), and the physical 
component score (−1.2; 95% CI −0.4 to −2.1; p<0.01). 
 
Table 2. Dose-response effects of aerobic exercise on quality of life outcomes in the BETA Trial 
Variable Baseline 1 year Least squares mean changea Least squares group differencea 
 M (SD) M (SD) M (95% CI) M (95% CI) p value 
Physical functioning 
 Moderate group (n = 185)  51.6 (5.4) 52.1 (6.7) +0.2 (−0.6 to 1.1) +0.8 (−0.3 to 2.0) 0.14 
 High group (n = 189)  51.4 (6.0) 52.8 (5.5) +1.1 (0.2 to 1.9) 
Role-physical 
 Moderate group (n = 185)  54.2 (7.3) 50.3 (12.8) −3.4 (−5.4 to −1.5) −0.2 (−2.5 to 2.8) 0.91 
 High group (n = 189)  52.8 (8.9) 50.1 (13.0) −3.3 (−5.3 to −1.3) 
Bodily pain 
 Moderate group (n = 185)  56.1 (6.1) 53.0 (9.4) −3.2 (−4.5 to −1.9) −0.0 (−1.8 to 1.7) 0.97 
 High group (n = 189)  55.4 (6.3) 52.6 (8.8) −3.2 (−4.5 to −1.9) 
General health 
 Moderate group (n = 185)  53.8 (6.7) 54.5 (7.2) +0.7 (−0.4 to 1.7) +0.1 (−1.2 to 1.5) 0.85 
 High group (n = 189)  53.1 (7.1) 54.2 (8.2) +0.8 (−0.2 to 1.8) 
Vitality 
 Moderate group (n = 185)  52.7 (8.9) 53.7 (9.1) +0.7 (−0.5 to 2.0) +0.9 (−0.7 to 2.5) 0.28 
 High group (n = 188)  52.1 (8.7) 54.3 (9.6) +1.6 (0.4 to 2.8) 
Social functioning 
 Moderate group (n = 185)  53.3 (6.7) 51.8 (8.5) −1.7 (−3.0 to −0.5) +0.1 (−1.5 to 1.8) 0.87 
 High group (n = 189)  53.3 (6.7) 51.9 (8.6) −1.6 (−2.8 to −0.3) 
Role-emotional 
 Moderate group (n = 185)  50.2 (12.1) 48.3 (14.8) −1.9 (−3.9 to 0.1) +1.3 (−1.4 to 3.9) 0.34 
Variable Baseline 1 year Least squares mean changea Least squares group differencea 
 M (SD) M (SD) M (95% CI) M (95% CI) p value 
 High group (n = 189)  50.8 (11.2) 49.9 (13.2) −0.6 (−2.6 to 1.4) 
Mental health 
 Moderate group (n = 185)  53.9 (7.2) 53.8 (7.1) −0.1 (−1.1 to 0.9) +1.2 (−0.1 to 2.5) 0.07 
 High group (n = 188)  53.6 (7.3) 54.9 (7.4) +1.1 (0.2 to 2.1) 
Physical health component 
 Moderate group (n = 185)  50.3 (5.8) 48.8 (9.0) −1.5 (−2.7 to −0.3) 0.0 (−1.6 to 1.6) 0.99 
 High group (n = 188)  49.4 (6.2) 48.4 (8.1) −1.5 (−2.7 to −0.3) 
Mental health component 
 Moderate group (n = 185)  52.2 (9.8) 51.8 (10.7) −0.4 (−1.8 to 0.9) +1.2 (−0.6 to 3.1) 0.19 
 High group (n = 188)  52.5 (9.4) 53.3 (10.4) +0.8 (−0.6 to 2.2) 
M mean, SD standard deviation, n sample size, CI confidence interval 
a Least squares mean change and least squares group difference in mean change are calculated based on a model 
adjusted for baseline value and location (Calgary/Edmonton) 
 
Table 3. Dose-response effects of aerobic exercise on sleep quality outcomes in the BETA Trial 
Variable Baseline 1 year Least squares mean changea Least squares group differencea 
 M (SD) M (SD) M (95% CI) M (95% CI) p value 
Subjective sleep quality 
 Moderate group (n = 183)  1.0 (0.7) 1.0 (0.7) −0.0 (−0.1 to 0.1) −0.1 (−0.2 to 0.1) 0.34 
 High group (n = 188)  1.0 (0.7) 0.9 (0.7) −0.1 (−0.2 to 0.0) 
Sleep latency 
 Moderate group (n = 183)  1.0 (0.8) 1.0 (1.0) +0.1 (0.0 to 0.2) −0.1 (−0.3, 0.1) 0.23 
 High group (n = 189)  1.0 (1.0) 0.9 (0.9) 0.0 (−0.1 to 0.1) 
Sleep duration 
 Moderate group (n = 183)  1.1 (1.0) 1.1 (0.9) −0.1 (−0.2 to 0.1) −0.1 (−0.2 to 0.1) 0.37 
 High group (n=189)  1.1 (1.0) 1.0 (1.0) −0.1 (−0.2 to −0.0) 
Habitual sleep efficiency 
 Moderate group (n = 183)  0.6 (0.9) 0.6 (0.8) 0.0 (−0.2, 0.1) 0.0 (−0.2, 0.1) 0.76 
 High group (n = 188)  0.6 (0.9) 0.6 (0.9) −0.1 (−0.2, 0.1) 
Sleep disturbances 
 Moderate group (n = 183)  1.2 (0.5) 1.2 (0.5) 0.0 (−0.1, 0.1) 0.0 (−0.1, 0.1) 0.44 
 High group (n = 188)  1.3 (0.5) 1.2 (0.5) 0.0 (−0.1, 0.1) 
Use of sleep medication 
 Moderate group (n = 183)  0.4 (0.9) 0.5 (0.9) 0.0 (−0.1, 0.1) 0.0 (−0.1, 0.2) 0.73 
 High group (n = 188)  0.4 (0.9) 0.5 (0.9) 0.0 (−0.1, 0.1) 
Daytime dysfunction 
 Moderate group (n = 183)  0.7 (0.6) 0.8 (0.6) 0.1 (0.0, 0.2) 0.0 (−0.1, 0.1) 0.67 
 High group (n = 188)  0.7 (0.6) 0.8 (0.7) 0.1 (−0.0, 0.2) 
Global score 
 Moderate group (n = 183)  6.0 (3.4) 6.1 (3.3) +0.1 (−0.3 to 0.5) −0.3 (−0.8 to 0.2) 0.28 
 High group (n = 188)  6.0 (3.6) 5.8 (3.7) −0.2 (−0.6 to 0.2) 
M mean, SD standard deviation, n sample size, CI confidence interval 
a Least squares mean change and least squares group difference in mean change are calculated based on a model 
adjusted for baseline value and location (Calgary/Edmonton) 
 
  
Table 4. Dose-response effects of aerobic exercise on psychosocial outcomes in the BETA Trial 
Variable Baseline 1 year Least squares mean changea Least Squares group differencea 
 M (SD) M (SD) M (95% CI) M (95% CI) p value 
Anxiety 
 Moderate group (n = 185)  16.3 (4.7) 16.4 (5.0) +0.1 (−0.7 to 0.8) +0.3 (−0.7 to 1.2) 0.60 0.61 
 High group (n = 189)  16.7 (4.9) 16.8 (5.8) +0.3 (−0.4 to 1.0) 
Depression 
 Moderate group (n = 186)  4.3 (4.0) 4.1 (4.1) −0.2 (−0.7 to 0.4) +0.1 (−0.7 to 0.8) 0.87 
 High group (n = 189)  3.8 (3.8) 3.9 (4.3) −0.1 (−0.7 to 0.5) 
Stress 
 Moderate group (n = 185)  17.1 (7.3) 17.1 (7.7) +0.2 (−0.9 to 1.2) +0.3 (−1.1 to 1.7) 0.69 
 High group (n = 190)  17.1 (7.1) 17.4 (8.1) +0.4 (−0.6 to 1.5) 
Self-esteem 
 Moderate group (n = 186)  33.7 (4.2) 34.5 (4.4) +0.9 (0.3 to 1.4) −0.4 (−1.1 to 0.3) 0.26 
 High group (n = 190)  33.3 (4.7) 33.8 (4.6) +0.5 (−0.1 to 1.0) 
Percent happiness 
 Moderate group (n = 185)  63.2 (23.8) 62.1 (24.3) −0.8 (−4.2 to 2.6) +4.1 (−0.4 to 8.6) 0.07 
 High group (n = 188)  62.7 (25.6) 65.9 (25.2) +3.3 (−0.1 to 6.7) 
M mean, SD standard deviation, n sample size, CI confidence interval 
a Least squares mean change and least squares group difference in mean change are calculated based on a model 
adjusted for baseline value and location (Calgary/Edmonton) 
 
 
Fig. 1. Change in health transition from baseline to 1 year in the combined sample in the BETA 
Trial 
 
Moderators of Dose-Response Effects on Quality of Life and Psychosocial Outcomes 
 
Participant preference for group assignment did not moderate the dose-response effects of 
aerobic exercise on any QoL, sleep quality, or psychosocial outcome (data not shown). The only 
significant or trend towards interactions between randomized group assignment and the proposed 
moderators were for global sleep quality. Specifically, marital status moderated the dose-
response effects of aerobic exercise on global sleep quality (p for interaction=0.01) such that 
unmarried women improved sleep quality with the high volume exercise program whereas 
married/common law women showed no dose-response effect (Fig. 2a). BMI showed a trend 
towards moderating the dose-response effects of aerobic exercise on global sleep quality (p for 
interaction=0.08) such that obese women improved sleep quality with the high volume exercise 
program whereas nonobese women showed no dose-response effect (Fig. 2b). 
 
 
Fig. 2. Dose-response effects of aerobic exercise on global sleep quality by marital status (a) and 




In this year-long randomized dose comparison trial of 300 versus 150 min/week of aerobic 
exercise in postmenopausal women, we found no evidence of dose-response effects on QoL, 
sleep quality, or psychosocial outcomes. In the Dose-Response to Exercise in Women (DREW) 
trial, Martin et al. [8] examined the effects of a 6-month, moderate intensity exercise program 
performed at three different exercise volumes (75, 150, and 225 min weekly) compared to a no 
intervention group in 430 postmenopausal women at high risk for cardiovascular disease. Results  
showed a general dose-response effect on all QoL subscales except bodily pain with the 
225 min/week group demonstrating the largest and broadest effects on the various QoL 
components. The Trial of Exercise on Aging and Memory (TEAM) used the same four-arm 
design as the DREW Trial but was focused on cognitive outcomes in 101 older adults [11]. In 
terms of the QoL outcomes, there were no statistically significant or meaningful dose-response 
effects of aerobic exercise among the control group and the three levels of exercise volume. In 
Project Four-IN-onE (FINE), 64 overweight and sedentary young men were randomized to a 
sedentary control group, 2000 kcal/week, or 3800 kcal/week of exercise energy expenditure for 
11 weeks [10]. Again, there were no differences in QoL between the exercise groups and the 
control group or between the two exercise volumes. Overall, these data suggest limited support 
for a dose-response effect of aerobic exercise on QoL and psychosocial outcomes in nonclinical 
adult populations. 
 
There are several possible explanations for the limited support for dose-response effects of 
aerobic exercise on QoL and psychosocial outcomes in nonclinical adult populations. First, 
higher doses of aerobic exercise may only produce modest additional improvements in the 
proposed biological and physiological mechanisms of improved psychosocial outcomes such as 
endorphins, monoamine neurotransmitters, cerebral blood flow, cardiovascular fitness, muscular 
strength, or body composition. For example, in the BETA Trial, the high volume group only 
improved VO2max by 1.1 ml/kg/min more than the moderate volume group and only lost an 
additional 1.0 kg of body fat [12]. Second, the lower volume exercise interventions are likely 
sufficient to address many of the psychosocial explanations for improved QoL and psychosocial 
outcomes such as increased social interaction, behavioral activation, expected benefits, 
distraction from daily worries, sense of achievement, and positive feedback from others [29]. 
Third, most dose-response aerobic exercise trials have increased the exercise dose by increasing 
session duration, rather than intensity or frequency, which may be less likely to improve the 
biological or physiological mechanisms [30–33] and, paradoxically, may actually increase 
boredom. Dose-response exercise trials based on increasing intensity (continuous or interval) or 
frequency are needed to address this question. Interestingly, Norris et al. [34] recently reported a 
pilot study suggesting that 3 days/week compared to 2 days/week of resistance training may 
actually blunt psychosocial outcomes in prostate cancer survivors (i.e., a negative dose-response 
effect for frequency). Finally, BETA participants were not selected based on any QoL or 
psychosocial impairments; therefore, there may be limited room for improvements in many of 
the outcomes (i.e., ceiling or floor effects). 
 
Most trials showing that exercise improves QoL and psychosocial outcomes in adults have 
compared an exercise intervention to no intervention [1–6]. Comparing exercise to nothing 
maximizes differences in all of the proposed mechanisms of psychosocial benefit. It is also 
possible that most or all of the QoL and psychosocial benefits of exercise are based on doing 
some exercise rather than none at all. Nevertheless, most exercise trials have compared at least 
the recommended volume of exercise (i.e., ≥150 min/week of moderate intensity exercise) to no 
exercise raising the possibility that a fairly large volume of exercise is needed for improved QoL 
and psychosocial functioning [1–6]. Interestingly, in the BETA Trial, the overall effects of both 
exercise volumes compared to baseline were mixed. There were overall improvements in 
physical functioning, vitality, general health, subjective sleep quality, self-esteem, and health 
transition; however, there were overall declines in role-physical, bodily pain, social functioning, 
and the physical component score. It is possible that the demanding nature of the exercise 
interventions (i.e., 5 days/week, moderate-to-vigorous intensity, 30 or 60 min) over a 1-year 
period induced some bodily pain which may have influenced overall changes in QoL, sleep 
quality, and psychosocial functioning. 
 
Our primary prespecified moderator in the BETA Trial was patient preference for group 
assignment. Patient preference for group assignment is a potentially important but often ignored 
factor in unblinded trials [35]. Participants assigned to their non-preferred intervention may 
suffer “resentful demoralization” or have a negative placebo response (i.e., expectation of less 
benefit), resulting in lower adherence and/or a negative psychosocial response to the intervention 
[35]. Participants assigned to their preferred intervention may have higher expectations of benefit 
(i.e., a placebo effect) or they may be better matched to the intervention [35]. Few exercise RCTs 
have examined patient preference effects in any population [36, 37]. In the Supervised Trial of 
Aerobic versus Resistance Training (START), we found that breast cancer patients who 
preferred resistance training improved quality of life when assigned to RET whereas patients 
with no preference improved quality of life when assigned to aerobic exercise [13]. In the BETA 
Trial, we found no evidence that participant preference for a given exercise volume moderated 
any of the dose-response effects of exercise on patient-reported outcomes. These data suggest 
that allowing postmenopausal women to choose their preferred exercise volume will not 
necessarily result in greater QoL or psychosocial improvements. 
 
The only evidence for possible moderation in the BETA Trial was for marital status and obesity 
with respect to sleep quality. Specifically, unmarried women benefited from the high volume 
program compared to the moderate volume program by about 1.5 points (a standardized effect 
size d of about 0.43) whereas married/common law women did not experience any benefit. It is 
possible that unmarried women may benefit more from the high volume intervention because 
they are less likely to have a bed partner who may interfere with the beneficial effects of 
exercise. It is also possible that unmarried women benefited more from the social aspects of the 
exercise intervention (i.e., social interactions with the trainers and other participants) because of 
less social support at home. Some of our previous exercise trials in breast cancer patients 
undergoing chemotherapy [13] and lymphoma patients [25] have shown that unmarried patients 
experience greater improvements in quality of life in response to the exercise intervention. 
Finally, it is possible that unmarried women benefit more from an intervention because they 
report more sleep problems [38, 39]; however, that was not the case in our study with no baseline 
differences in sleep quality between married and unmarried women (p = 0.58). 
 
We also found a trend that obese women improved sleep quality with the high volume exercise 
program but nonobese women did not. Specifically, obese women improved their sleep quality 
by about 0.9 points, equivalent to a standardized effect size d of about 0.25. It is possible that 
obese women benefitted more from the high volume program because they have worse sleep 
quality to begin with and more room for improvement [40–44]; however, there was only a trend 
towards worse sleep quality for obese women at baseline in our study (p = 0.12). It is also 
possible that they benefited more because they experienced greater weight loss that may be tied 
to improved sleep quality [40–44]. In the BETA Trial, we found a significant interaction between 
obesity and weight loss such that obese women lost 2 kg of weight more with the high volume 
program whereas nonobese women showed no dose-response effect for weight loss. 
Nevertheless, given the large number of analyses, it is possible that both of these interactions are 
chance findings. 
 
The strengths of the BETA trial are that it is one of the few dose-response exercise trials in 
postmenopausal women, the exercise intervention was 1 year long and mostly supervised, 
adherence in both groups was excellent, loss-to-follow-up was minimal, the sample size was 
large, and we had comprehensive and validated measures of QoL, sleep quality, and 
psychosocial outcomes. The limitations of BETA include the highly select population based on 
education, ethnicity, and health status that restricts the generalizability of the findings; the fact 
that the women were not selected based on poor QoL or psychosocial functioning; and the large 
number of analyses which increases the chances of false positive findings. 
 
In summary, the BETA Trial showed that a higher volume of aerobic exercise, approximately 
double the minimum public health guideline, did not provide any additional QoL or psychosocial 
benefits in inactive postmenopausal women compared to the minimum public health guideline, 
even for women who preferred the higher volume program. Nevertheless, higher doses of 
aerobic exercise derived by increasing session duration may produce other health benefits for 
postmenopausal women including fat loss, improved cardiorespiratory fitness, and lower risk of 
breast cancer and other chronic diseases [12]. Future trials may examine the dose-response 
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